Cargando…
Therapeutic Targeting of B Cells and T Cells in Autoimmune Diabetes: Is It a Solution?
Autor principal: | Chatenoud, Lucienne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717844/ https://www.ncbi.nlm.nih.gov/pubmed/23881196 http://dx.doi.org/10.2337/db13-0684 |
Ejemplares similares
-
Targeting activated T cells in type I diabetes and islet transplantation
por: Chatenoud, Lucienne
Publicado: (2011) -
B cells as a therapeutic target in autoimmune disease
por: Goronzy, Jörg J, et al.
Publicado: (2003) -
Targeting B-cells Mitigates Autoimmune Diabetes in NOD Mice: What Is Plan B?
por: Smith, Susan H., et al.
Publicado: (2009) -
Key Role of the GITR/GITRLigand Pathway in the Development of Murine Autoimmune Diabetes: A Potential Therapeutic Target
por: You, Sylvaine, et al.
Publicado: (2009) -
Therapeutic Use of a Selective S1P(1) Receptor Modulator Ponesimod in Autoimmune Diabetes
por: You, Sylvaine, et al.
Publicado: (2013)